Dengue Virus 2 NS2B Targets MAVS and IKKε to Evade the Antiviral Innate Immune Response

키워드

참고문헌 (44)

1. Bhatt S, "The global distribution and burden of dengue", Nature, 496, pp.504~507 (2013)
2. Bhatt P, "Current understanding of the pathogenesis of Dengue Virus infection", Curr. Microbiol, 78, pp.17~32 (2021)
3. Harapan H, "Dengue: a minireview", Viruses, 12, pp.829~ (2020)
4. Park Jisang, "Current status and perspectives on vaccine development against dengue virus infection", The Journal of Microbiology, 60(3), pp.247~254 (2022), 한국미생물학회[DOI]
5. Wilder-Smith A, "Dengue", Lancet, 393, pp.350~363 (2019)
6. Ngono AE, "Immune response to Dengue and Zika", Ann. Rev. Immunol, 36, pp.279~308 (2018)
7. Nasirudeen AM, "RIG-I, MDA5 and TLR3 synergistically play an important role in restriction of dengue virus infection", PLoS Negl. Trop. Dis, 5, pp.e926~ (2011)
8. Uno N, "Dengue virus and the host innate immune response", Emerg. Microbes Infect, 7, pp.167~ (2018)
9. Seth RB, "Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3", Cell, 122, pp.669~682 (2005)
10. Xu LG, "VISA is an adapter protein required for virus-triggered IFN-beta signaling", Mol. Cell, 19, pp.727~740 (2005)
11. Meylan E, "Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus", Nature, 437, pp.1167~1172 (2005)
12. Kawai T, "IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction", Nat. Immunol, 6, pp.981~988 (2005)
13. Fang R, "MAVS activates TBK1 and IKKε through TRAFs in NEMO dependent and independent manner", PLoS Pathog, 13, pp.e1006720~ (2017)
14. Schoggins JW, "Interferon-stimulated genes and their antiviral effector functions", Curr. Opin. Virol, 1, pp.519~525 (2011)
15. Schoggins JW, "Recent advances in antiviral interferon-stimulated gene biology", F1000Res, 7, pp.309~ (2018)
16. Dalrymple NA, "Dengue Virus NS proteins inhibit RIG-I", MAVS signaling by blocking TBK1, mBio, pp.2015, 6[DOI]
17. He Z, "Dengue Virus subverts host innate immunity by targeting adaptor protein MAVS", J. Virol, 90, pp.7219~7230 (2016)
18. Wahaab A, "Potential role of flavivirus NS2B-NS3 proteases in viral pathogenesis and anti-flavivirus drug discovery employing animal cells and models: a review", Viruses, 14, pp.44~ (2021)
19. Angleró-Rodríguez YI, "Dengue virus subverts the interferon induction pathway via NS2B", 3 protease-IκB kinase epsilon interaction, 2014, pp.21, 29~38
20. Yu CY, "Dengue virus targets the adaptor protein MITA to subvert host innate immunity", PLoS Pathog, 8, pp.e1002780~ (2012)
21. Aguirre S, "Dengue virus NS2B protein targets cGAS for degradation and prevents mitochondrial DNA sensing during infection", Nat. Microbiol, 2, pp.17037~ (2017)
22. Aguirre S, "DENV inhibits type I IFN production in infected cells by cleaving human STING", PLoS Pathog, 8, pp.e1002934~ (2012)
23. Muñoz-Jordan JL, "Inhibition of interferon signaling by dengue virus", Proc. Natl. Acad. Sci. USA, 100, pp.14333~14338 (2003)
24. Ashour J, "NS5 of dengue virus mediates STAT2 binding and degradation", J. Virol, 83, pp.5408~5418 (2009)
25. Mazzon M, "Dengue virus NS5 inhibits interferon-alpha signaling by blocking signal transducer and activator of transcription 2 phosphorylation", J. Infect. Dis, 200, pp.1261~1270 (2009)
26. Morrison J, "Dengue virus co-opts UBR4 to degrade STAT2 and antagonize type I interferon signaling", PLoS Pathog, 9, pp.e1003265~ (2013)
27. Yoneyama M, "The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses", Nat. Immunol, 5, pp.730~737 (2004)
28. Nie Y, "GPATCH3 negatively regulates RLR-mediated innate antiviral responses by disrupting the assembly of VISA signalosome", PLoS Pathog, 13, pp.e1006328~ (2017)
29. Li WW, "Ubiquitination of TLR3 by TRIM3 signals its ESCRT-mediated trafficking to the endolysosomes for innate antiviral response", Proc. Natil. Acad. Sci. USA, 117, pp.23707~23716 (2020)
30. Ren Z, "Regulation of MAVS expression and signaling function in the antiviral innate immune response", Front. Immunol, 11, pp.1030~ (2020)
31. Niyomrattanakit P, "Identification of residues in the dengue virus type 2 NS2B cofactor that are critical for NS3 protease activation", J. Virol, 78, pp.13708~13716 (2004)
32. Liu S, "MAVS recruits multiple ubiquitin E3 ligases to activate antiviral signaling cascades", eLife, 2, pp.e00785~ (2013)
33. Xu H, "Structural basis for the prion-like MAVS filaments in antiviral innate immunity", eLife, 3, pp.e01489~ (2014)
34. Liu S, "Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation", Science, 347, pp.aaa2630~ (2015)
35. Sharma A, "The MAVS Immune recognition pathway in viral infection and sepsis", Antioxid Redox Signal, 35, pp.1376~1392 (2021)
36. Chen Y, "MAVS: A two-sided CARD Mediating antiviral innate immune signaling and regulating immune homeostasis", Front. Microbiol, 12, pp.744348~ (2021)
37. Ma J, "Zika virus non-structural protein 4A blocks the RLR-MAVS signaling", Front. Microbiol, 9, pp.1350~ (2018)
38. Li W, "Zika virus circumvents host innate immunity by targeting the adaptor proteins MAVS and MITA", FASEB J, 33, pp.9929~9944 (2019)
39. Hu Y, "Zika virus antagonizes interferon response in patients and disrupts RIG-IMAVS interaction through its CARD-TM domains", Cell Biosci, 9, pp.46~ (2019)
40. Li XD, "Hepatitis C virus protease NS3", 4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity, 2005, pp.102, 17717~17722
41. Bellecave P, "Cleavage of mitochondrial antiviral signaling protein in the liver of patients with chronic hepatitis C correlates with a reduced activation of the endogenous interferon system", Hepatology, 51, pp.1127~1136 (2010)
42. Bender S, "Activation of type I and III interferon response by mitochondrial and peroxisomal MAVS and inhibition by hepatitis C virus", PLoS Pathog, 11, pp.e1005264~ (2015)
43. Ferreira AR, "Hepatitis C virus NS3-4A inhibits the peroxisomal MAVS-dependent antiviral signalling response", J. Cell. Mol. Med, 20, pp.750~757 (2016)
44. Zhou P, "Tembusu virus nonstructural protein 2B antagonizes type I interferon production by targeting MAVS for degradation", J. Virol, 96, pp.e0081622~ (2022)

관련 논문AI추천